AbstractA series of efficient ruthenium catalysts has been developed for the asymmetric hydrogenation and transfer hydrogenation of ketones with high reactivities and selectivities. The new chiral bisdihydrobenzooxaphosphole (BIBOP)/diamine‐ruthenium complexes catalyzed the enantioselective hydrogenation of substrates such as aryl and heteroaryl cyclic and alkyl ketones with substrate/catalyst (S/C) ratios of up to 100,000. The opposite sense of enantioselectivity can be obtained by proper selection of a diamine with a given chirality of the phosphine. The usefulness of the new system has been demonstrated in the asymmetric hydrogenation of a complex synthetic intermediate towards cholesteryl ester transfer protein (CETP) inhibitors at S/C 20,000 on large‐scale operation.magnified image
[EN] NOVEL RUTHENIUM CATALYSTS AND THEIR USE FOR ASYMMETRIC REDUCTION OF KETONES<br/>[FR] NOUVEAUX CATALYSEURS AU RUTHÉNIUM ET LEUR UTILISATION POUR LA RÉDUCTION ASYMÉTRIQUE DE CÉTONES
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2015002769A1
公开(公告)日:2015-01-08
Disclosed are novel ruthenium compounds of formula (Ia) and (Ib): wherein R1 and the moiety L ∩ L are defined herein. Also disclosed is a process for using these novel ruthenium compounds as catalysts for asymmetric hydrogenation and transfer hydrogenation of ketones with high reactivities and excellent selectivities.
NOVEL RUTHENIUM CATALYSTS AND THEIR USE FOR ASYMMETRIC REDUCTION OF KETONES
申请人:HADDAD Nizar
公开号:US20150005500A1
公开(公告)日:2015-01-01
Disclosed are novel ruthenium compounds of formula (Ia) and (Ib):
wherein R
1
and the moiety
are defined herein. Also disclosed is a process for using these novel ruthenium compounds as catalysts for asymmetric hydrogenation and transfer hydrogenation of ketones with high reactivities and excellent selectivities.
Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
申请人:Eisai R&D Management Co., Ltd.
公开号:EP2261218A2
公开(公告)日:2010-12-15
The present invention relates to a process for preparing a compound of formula (6a):
which comprises the step of:
subjecting a compound of formula (5a):
and a compound of formula (4a):
to a coupling reaction,
Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology
作者:Andrew S. Rowan、Thomas S. Moody、Roger M. Howard、Toby J. Underwood、Iain R. Miskelly、Yanan He、Bo Wang
DOI:10.1016/j.tetasy.2013.09.015
日期:2013.11
Libraries of highly enantioenriched secondary alcohols in both enantiomeric forms were synthesised by enzymatic reduction of their parent ketones using selectAZyme (TM) carbonyl reductase (CRED) technology. Commercially available CREDs were able to reduce a range of substrate classes efficiently and with very high enantioselectivity. Matching substrate classes to small subsets of CREDs enabled the fast development of preparative bioreductions and the rapid generation of 100-1500 mg samples of chiral alcohols in typically >95% ee and the majority in >= 99.0% ee. The conditions for small scale synthesis were then scaled up to 0.5 kg to deliver one of the chiral alcohols, (S)-1-(4-bromophenyl)-2-chloroethanol, in 99.8% ee and 91% isolated yield. (C) 2013 Elsevier Ltd. All rights reserved.